Affymetrix
Quick Order
Welcome, Guest
About Affymetrix

Products

Email | Print
Bookmark and Share

GeneChip® miRNA Arrays

GeneChip® miRNA Arrays are powerful tools for studying the role of small non-coding RNA (miRNA, snoRNA, and scaRNA) and their importance in cancer and other diseases.

Part # Description Unit Size Your Price (USD)
Qty
902445
GeneChip® miRNA 4.0 Array and Flashtag™ Bundle
Sufficient for 10 samples    Please Inquire
902446
GeneChip® miRNA 4.0 Array and Flashtag™ Bundle
Sufficient for 30 samples    Please Inquire
902411
GeneChip® miRNA 4.0 Array
Contains 2 arrays    Please Inquire
902412
GeneChip® miRNA 4.0 Array
Contains 6 arrays    Please Inquire
902413
GeneChip® miRNA 4.0 Array
Contains 30 arrays    Please Inquire
902017
GeneChip® miRNA 3.0 Array
Contains 2 arrays    Please Inquire
902018
GeneChip® miRNA 3.0 Array
Contains 6 arrays    Please Inquire
902019
GeneChip® miRNA 3.0 Array
Contains 30 arrays    Please Inquire
901753
GeneChip® miRNA 2.0 Array
Contains 2 arrays    Please Inquire
901754
GeneChip® miRNA 2.0 Array
Contains 6 arrays    Please Inquire
901755
GeneChip® miRNA 2.0 Array
Contains 30 arrays    Please Inquire
     

Many diseases, including cancer, are frequently described as diseases of disordered gene expression. It is estimated that more than 30% of protein translation of coding genes is regulated by miRNA. There is also a large amount of growing evidence suggesting miRNA interacts with long non-coding RNA in the signaling networks that regulate alternative splicing events, which impacts cellular processes such as apoptosis, proliferation, and differentiation—all of which have shown to be causative elements in diseases such as cancer.

Measuring the changes in these critical nodes of regulation is extremely important for deciphering the biological context of differentially expressed genes. This new array design is a powerful tool for studying the role of small non-coding RNAs and their involvement in a broad spectrum of developmental and physiological mechanisms.

To keep pace with the discovery of new and novel miRNA, Affymetrix is pleased to announce the release of the NEW GeneChip® miRNA 4.0 Array to our growing catalog of miRNA arrays. This new array offers updated content with the same high performance as the previous generation array.

Affymetrix miRNA 4.0 Arrays help bring you closer to biology with:

  • Comprehensive coverage – Designed to interrogate all mature miRNA sequences in miRBase Release 20
  • Easily correlate miRNA results – Analysis files contain host gene ID, predicted and validated miRNA target genes, and clustered miRNA information
  • Easy analysis – Analyze human, mouse, rat, or every miRNA for all species using the same array
  • Low sample input – Requires as little as 130 ng total RNA
  • Simple, fast, and free analysis solution – Coupled with Affymetrix® Expression Console™ Software and Affymetrix® Transcriptome Analysis Console (TAC) Software, researchers have a complete solution from data to decision-making in minutes


  • Performance specifications miRNA 2.0 miRNA 3.0 miRNA 4.0

    Reproducibility (inter– and intra–lot)

    >0.95

    >0.95

    >0.95

    Transcripts detected at 1.0 amol

    85%

    85%

    85%

    Dynamic range

    >3 logs

    >3 logs

    4 logs

    Total RNA input

    100–500 ng

    130–500 ng

    130–500 ng

    Array contents miRNA 2.0 miRNA 3.0 miRNA 4.0

    miRBase version

    15

    17

    20

    Organisms

    131

    153

    203

    Total mature miRNA probe sets

    15,644

    19,724

    30,424

    Probes/probe set for mature miRNA

    9

    9

    9

    Human mature miRNA

    1,105

    1,733

    2.578

    Mouse mature miRNA

    722

    1,111

    1,255

    Rat mature miRNA

    389

    680

    728

    Human snoRNA, CDBox RNA, H/ACA Box RNA and scaRNA

    2,334

    2,216

    1,996

    Human pre–miRNA

    1,105

    1,658

    2.025

    Mouse pre–miRNA

    690

    855

    1,255

    Rat pre–miRNA

    389

    486

    490

    For Research Use Only. Not for use in diagnostic procedures.

     

Back to Top >

Back to Top >